Research Paper Volume 15, Issue 15 pp 7616—7636
An angiogenesis-related lncRNA signature predicts the immune microenvironment and prognosis of breast cancer
Figure 6. Immune infiltration landscape and immune response analysis of patients with breast cancer. The fraction of immune cells calculated by (A) CIBERSORT and (B) ssGSEA algorithms. (C) Correlation analysis of prognostic ARL and 22 types of immune cells. (D) Correlation analysis of prognostic ARL and 23 types of immune cells. (E) Immunophenoscore (IPS) analysis. (F) Tumor immune dysfunction and exclusion (TIDE) analysis. (G) Immune function score of patients in low-risk group and high-risk group.